DEA Interim Final Rules Breakdown
Aug 28, 2020 1:18:59 PM / by Brett Puffenbarger posted in Extraction, DEA, Farm Bill
2020 FDA Compliance Webinar Series | Ep. #2
Jun 16, 2020 4:34:02 PM / by Michael Budd posted in Education, Legislation, Compliance, CBD, Extraction, GMP, Vanguard Scientific, FDA, Webinar
On June 10, 2020, the team from Vanguard teamed up with Canna Advisors and Rymedi to once again welcome hundreds of guests from around the globe for another episode of our webinar series on forthcoming FDA regulation, and GMP compliance for domestic market and export-readiness in the hemp extraction, processing, and manufacturing industry...
2020 FDA Webinar Series | Episode #1 Speaker Profiles
Apr 23, 2020 4:19:58 PM / by Michael Budd posted in Education, Legislation, Compliance, CBD, Extraction, GMP, Vanguard Scientific, FDA, Webinar
On April 22, 2020, the team from Vanguard welcomed hundreds of guests from around the globe for the first episode of Vanguard Scientific's 2020 webinar series on forthcoming FDA regulation for the hemp extraction, processing, and manufacturing industry...
US/UK Regulatory Warning to the Hemp Industry: Learn to Pivot
Apr 6, 2020 3:53:43 PM / by Vanguard Scientific posted in Extraction, GMP, FDA
On March 5th, the Food and Drug Administration released their most recent commentary on cannabidiol regulation, with a stated focus on protecting public health and providing market clarity. Arriving more than a month after its expected delivery date, the congressional report offered little in the way of material guidance for an industry frustrated by its unending purgatorial wait. Now, with little to work against in terms of timelines or anticipated regulatory requirements, the industry is left staring across international and industry borders to attempt to define its future.